BioTech Nation: Episode 15-02 Bacteria
By: Dr. Moira Gunn | Source: BioTech Nation
Read or purchase full article from: BioTech Nation
Press Releases
Pylum Biosciences Collaborates on Research Published in the Journal Nature
AvidBiotics’ Scientists Co-author Publication in Science Translational Medicine Describing A New Class of Targeted Antibacterial Agents for Clostridium difficile
Study Published in mBio Shows that Avidocin™ Proteins Prevent Clostridium Difficile Infection in Mice without Harming Protective Gut Bacteria
AvidBiotics Granted U.S. Patent for Bactericidal Proteins that Selectively Kill C. Difficile
AvidBiotics Awarded SBIR Grant for Avidocin™ Antibacterial Proteins Against Clostridium difficile
Articles